Biotech Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC) October 25, 2024
Biotech Final Day of Global Health Exhibition Celebrates the Next Generation of Health Innovators October 24, 2024
Biotech Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024 October 22, 2024
Biotech MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum October 20, 2024
Biotech 111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow October 18, 2024
Biotech Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer October 16, 2024
Search
Biotech
October 25, 2024
October 24, 2024
October 23, 2024
October 22, 2024
October 21, 2024
October 20, 2024
October 19, 2024
October 18, 2024
October 17, 2024
October 16, 2024
